Trial record 1 of 29 for:
CAR 107
Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC. (SCLC)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05271292 |
|
Recruitment Status :
Recruiting
First Posted : March 9, 2022
Last Update Posted : March 19, 2024
|
Sponsor:
Chipscreen Biosciences, Ltd.
Information provided by (Responsible Party):
Chipscreen Biosciences, Ltd.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | March 2024 |
| Estimated Study Completion Date : | April 2024 |
Publications of Results: